Pfizer's mRNA Partner Forced to Sell Manufacturing Facilities in the U.S.

We’re just starting to see the early effects of the new pro-America and pro-humanity policies passed by the House with today’s announcement that WuXi is being forced to sell-off their US facilities.

October 3, 2024: Wuxi Biologics is Pfizer’s mRNA-LNP manufacturing partner for vaccines and is headquartered in China.

WuXi’s Exponential Growth in the United States